VIVO CAPITAL
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
VIVO CAPITAL
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
(650) 688-0818
Email Addresses:
[email protected]
Technology used in webpage:
SPF DNS Made Easy DNS DNS Made Easy Tiggee
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-08 | Serán Bioscience | Serán Bioscience acquired by Vivo Capital | N/A |
| 2016-12-19 | Angiotech Pharmaceuticals | Angiotech Pharmaceuticals acquired by Vivo Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-11 | Klavi | Vivo Capital investment in Series A - Klavi | 15 M USD |
| 2022-07-11 | Inspirna | Vivo Capital investment in Series D - Inspirna | 55.1 M USD |
| 2022-07-06 | Tebra | Vivo Capital investment in Series B - Tebra | 72 M USD |
| 2022-06-28 | Cerebral Therapeutics | Vivo Capital investment in Series C - Cerebral Therapeutics | 40 M USD |
| 2022-06-09 | DBV Technologies | Vivo Capital investment in Post-IPO Equity - DBV Technologies | 181 M EUR |
| 2022-04-25 | Visirna Therapeutics | Vivo Capital investment in Seed Round - Visirna Therapeutics | 60 M USD |
| 2022-03-23 | Ocelot Bio | Vivo Capital investment in Series A - Ocelot Bio | 36 M USD |
| 2021-12-08 | Avistone Pharmaceuticals | Vivo Capital investment in Private Equity Round - Avistone Pharmaceuticals | 200 M USD |
| 2021-11-29 | Ablaze Pharmaceuticals | Vivo Capital investment in Series A - Ablaze Pharmaceuticals | 75 M USD |
| 2021-10-19 | HistoWiz | Vivo Capital investment in Series A - HistoWiz | 32.25 M USD |
Newest Events participated